Machine learning algorithms to estimate everolimus exposure trained on simulated and patient pharmacokinetic profiles.


Journal

CPT: pharmacometrics & systems pharmacology
ISSN: 2163-8306
Titre abrégé: CPT Pharmacometrics Syst Pharmacol
Pays: United States
ID NLM: 101580011

Informations de publication

Date de publication:
08 2022
Historique:
revised: 26 04 2022
received: 11 02 2022
accepted: 28 04 2022
pubmed: 24 5 2022
medline: 19 8 2022
entrez: 23 5 2022
Statut: ppublish

Résumé

Everolimus is an immunosuppressant with a small therapeutic index and large between-patient variability. The area under the concentration versus time curve (AUC) is the best marker of exposure but measuring it requires collecting many blood samples. The objective of this study was to train machine learning (ML) algorithms using pharmacokinetic (PK) profiles from kidney transplant recipients, simulated profiles, or both types, and compare their performance for everolimus AUC

Identifiants

pubmed: 35599364
doi: 10.1002/psp4.12810
pmc: PMC9381914
doi:

Substances chimiques

Immunosuppressive Agents 0
Everolimus 9HW64Q8G6G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1018-1028

Informations de copyright

© 2022 The Authors. CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.

Références

Clin Pharmacokinet. 2012 Jul 1;51(7):467-80
pubmed: 22624503
Ther Drug Monit. 2016 Apr;38(2):143-69
pubmed: 26982492
Clin Pharmacokinet. 2018 Nov;57(11):1459-1469
pubmed: 29556934
Clin Pharmacokinet. 2021 Feb;60(2):191-203
pubmed: 32720301
Clin Pharmacol Ther. 1979 Sep;26(3):294-305
pubmed: 466923
Transplantation. 2010 Jul 15;90(1):31-7
pubmed: 20517177
Transplantation. 2004 Nov 15;78(9):1332-40
pubmed: 15548972
Ther Drug Monit. 2019 Jun;41(3):261-307
pubmed: 31045868
Clin Pharmacokinet. 2021 Feb;60(2):223-233
pubmed: 32794122
Ther Drug Monit. 2013 Jun;35(3):322-7
pubmed: 23666572
Pharmacol Res. 2021 May;167:105578
pubmed: 33775863
Am J Transplant. 2004 Apr;4(4):626-35
pubmed: 15023156
Clin Pharmacol Ther. 2001 Jan;69(1):48-56
pubmed: 11180038
Transplantation. 1997 Jul 15;64(1):36-42
pubmed: 9233698
CPT Pharmacometrics Syst Pharmacol. 2019 Dec;8(12):883-893
pubmed: 31652028
Clin Pharmacol Ther. 2020 Apr;107(4):871-885
pubmed: 32128792
Clin Pharmacol Ther. 2021 Aug;110(2):370-379
pubmed: 33624286
Clin Pharmacokinet. 2004;43(2):83-95
pubmed: 14748618
CPT Pharmacometrics Syst Pharmacol. 2022 Aug;11(8):1018-1028
pubmed: 35599364
Clin Pharmacol Ther. 2021 Aug;110(2):361-369
pubmed: 33253425

Auteurs

Marc Labriffe (M)

Pharmacology & Transplantation, INSERM U1248, Université de Limoges, Limoges, France.
Department of Pharmacology, Toxicology and Pharmacovigilance, CHU de Limoges, Limoges, France.

Jean-Baptiste Woillard (JB)

Pharmacology & Transplantation, INSERM U1248, Université de Limoges, Limoges, France.
Department of Pharmacology, Toxicology and Pharmacovigilance, CHU de Limoges, Limoges, France.

Jean Debord (J)

Pharmacology & Transplantation, INSERM U1248, Université de Limoges, Limoges, France.
Department of Pharmacology, Toxicology and Pharmacovigilance, CHU de Limoges, Limoges, France.

Pierre Marquet (P)

Pharmacology & Transplantation, INSERM U1248, Université de Limoges, Limoges, France.
Department of Pharmacology, Toxicology and Pharmacovigilance, CHU de Limoges, Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH